Brendan Kennedy from Privateer Holdings and Adam Bierman from MedMen join me for a panel discussion at the IMN Institutional Capital and Cannabis Conference. The panel is set up as a debate between the concepts of plant touching investment vs. ancillary here in the US. The US unfortunately, is starting to fall behind the rest of the world in regards to federal regulations. So despite Brendan’s being invested in plant touching opportunities in Canada and other countries, his point of view in the US is that for the time being, the opportunity is investing in brands. Adam’s point of view is that now is the time to invest in the infrastructure of what will be the cannabis economy right here at home. It’s a thought-provoking, lively conversation in front of a group of investors.